The majority of patients with acute myeloid leukaemia (AML) are elderly. Advancements in
supportive care and regimen intensification have resulted in improvements in clinical …

Acute myeloid leukaemia (AML) is a heterogenous disease. Prognosis of AML is influenced
both by patient‐specific as well as disease‐specific factors. Age is the most prominent …

Acute myeloid leukemia (AML) is most common in the elderly, and most elderly are thought
to be unfit for intensive treatment because of the risk of fatal toxicity. The Swedish Acute …

BACKGROUND. Elderly patients with acute myeloid leukemia (AML) have a poor prognosis,
which is explained by the disease itself and by host‐related factors. The objective of this …

Introduction: Hyperleukocytosis is defined as a white blood cell count greater than
100,000/mL in patients affected by acute leukemia and often it is associated with increased …

Dysregulation of apoptotic machinery is one mechanism by which acute myeloid leukemia
(AML) acquires a clonal survival advantage. B-cell lymphoma protein-2 (BCL2) …

Hyperleukocytic acute myeloid leukaemia is considered to have a poor prognosis due to
high early death rate secondary to leukostasis. Supportive treatments do not seem to have …

Despite the fact that malignancies are associated with hematological abnormalities, some
clinical studies have been unable to detect such a relation. The aim of our study was to …

Age is a dominant predictor of outcome in acute myeloid leukemia (AML). However, it is not
clear to which extent comorbidities contribute to this effect. The objective of this study was to …

Purpose: The aim of this study was to investigate the association between preoperative
leukocyte and platelet counts and the stage of the disease in patients with endometrial …